Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EQ Equillium Inc.

盘前交易 05-26 06:16:50 EDT

2.26

+0.05

+2.26%

最高2.39	最低2.20	成交量46.74万
今开2.23	昨收2.21	日振幅8.60%
总市值1.43亿	流通市值7,119万	总股本6,323万
成交额107.10万	换手率1.48%	流通股本3,150万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EQ","market":"US","secType":"STK","nameCN":"Equillium Inc.","latestPrice":2.26,"timestamp":1779480000000,"preClose":2.21,"halted":0,"volume":467446,"delay":0,"changeRate":0.02262443438914019,"floatShares":31498300,"shares":63226556,"eps":-0.30137652,"marketStatus":"盘前交易","change":0.05,"latestTime":"05-26 06:16:50 EDT","open":2.23,"high":2.39,"low":2.2,"amount":1070960.7626508,"amplitude":0.085973,"askPrice":2.55,"askSize":100,"bidPrice":2.02,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.30137652,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779802200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1539316800000,"exchange":"NASDAQ","adjPreClose":2.26,"postHourTrading":{"tag":"盘后","latestPrice":2.26,"preClose":2.26,"latestTime":"19:54 EDT","volume":178,"amount":403.9213,"timestamp":1779494059557,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3163962788228405,"impliedVol":1.424,"impliedVolPercentile":0.62},"requestUrl":"/m/hq/s/EQ","defaultTab":"news","newsList":[{"id":"2629584893","title":"东风汽车全新一代概念车EQ-REBORN亮相，致敬1975年军车","url":"https://stock-news.laohu8.com/highlight/detail?id=2629584893","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629584893?lang=zh_cn&edition=full","pubTime":"2026-04-24 09:37","pubTimestamp":1776994638,"startTime":"0","endTime":"0","summary":"IT之家 4 月 24 日消息，在今日的 2026 东风汽车北京国际车展发布会上，东风汽车全新一代概念车正式亮相。这款概念车灵感来自东风 1975 年的 EQ240 军车，定名 EQ-REBORN。该车的造型方正，车头处配有点阵屏可显示信息，车顶配有多个无人机，定位智能轻越野车型。IT之家注意到，发布会现场只展示了该车的外观和部分内饰画面，配置信息暂未公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8sZyfreKSxc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK1523","EQ","BK4568","HK0000252160.HKD","HK0000252152.HKD","BK4139","BK1539","00489","BK1119","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183859739","title":"Equillium Inc. 股东售股计划：包含可行使预融资权证发行的1770万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1183859739","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183859739?lang=zh_cn&edition=full","pubTime":"2026-04-08 05:17","pubTimestamp":1775596630,"startTime":"0","endTime":"0","summary":"Equillium Inc. 宣布其股东售股计划中，包含一项重要条款：通过行使预融资权证，可发行高达1770万股的公司普通股。这一安排为股票的潜在增发提供了明确路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQ","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186611042","title":"Equillium获RA资本管理3500万美元融资 加速EQ504临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1186611042","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186611042?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:05","pubTimestamp":1773403550,"startTime":"0","endTime":"0","summary":"此次融资将强化公司资产负债表，推动关键候选药物EQ504跨越临床里程碑。预计净收益与现有现金储备将支撑公司运营至2029年。2026年3月13日，专注于治疗严重自身免疫及炎症疾病的生物技术公司Equillium Inc.宣布与RA资本管理达成最终证券购买协议，后者将提供约3500万美元的总融资。在扣除相关费用前，本次融资总额预计达3500万美元。Equillium认为EQ504单药或联合疗法在溃疡性结肠炎领域具有广阔治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RA","BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617570598","title":"“新物种”Robot Phone能给手机硬件创新带来什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2617570598","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617570598?lang=zh_cn&edition=full","pubTime":"2026-03-05 08:07","pubTimestamp":1772669232,"startTime":"0","endTime":"0","summary":"【“新物种”Robot Phone能给手机硬件创新带来什么？】新物种“RobotPhone”在2026年世界移动通信大会（MWC26）上引起了不小的关注度。3月3日，MWC第二天，荣耀的MWC展台依然挤满了观众，人们在围观新物种“Robot Phone”。舞台上有舞者在跳舞，Robot Phone通过延伸出的镜头来追踪舞者的动作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603053662396561.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603053662396561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QCMD","LU0061475181.USD","LU1035775433.USD","BK4605","BK4575","SG9999002232.USD","BK4573","LU1244550494.USD","LU2106854487.HKD","BK4515","BK4612","IQ","LU0081259029.USD","IE00BVYPNQ40.USD","BK4526","SG9999001424.SGD","BK4543","IE00BGHQDM52.EUR","LU2247934214.USD","SG9999015952.SGD","LU1046421795.USD","BK4512","BK4588","BK4579","GB00BDT5M118.USD","BK4561","LU1084165304.USD","LU1069344957.HKD","AIYY","LU0868494617.USD","QCML","BK4023","BK4528","QCMU","LU1917777945.USD","BK4554","LU1974910355.USD","BK4552","BK4534","SG9999002224.SGD","SG9999015978.USD","BK4505","LU2023250504.SGD","QCOM","EQ","BK4587","BK4551","LU1823568750.SGD","BK4598"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2616144822","title":"荣耀CEO李健提出AHI理念：让AI既有IQ又有EQ","url":"https://stock-news.laohu8.com/highlight/detail?id=2616144822","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616144822?lang=zh_cn&edition=full","pubTime":"2026-03-01 20:33","pubTimestamp":1772368380,"startTime":"0","endTime":"0","summary":"新浪科技讯 北京时间3月1日晚间消息，在今日的荣耀MWC 2026全球发布会上，荣耀CEO李健发表演讲。\n　　他提出Augmented Human Intelligence（简称AHI）理念，以实现AI从智能度到生命感的双重跃升，让AI既有IQ，又有EQ，并创造性地将AHI理念融入其阿尔法战略落地进程中。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：何俊熹","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2026-03-01/doc-inhpnwmn6008247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4505","BK4526","BK4139","EQ","IQ","BK4097","BK4108","BK4167","BK4531","BK4568","AHI","BK4552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614127001","title":"Equillium, Inc.盘中异动 早盘急速下挫6.01%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614127001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614127001?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:02","pubTimestamp":1772118120,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日23时02分，Equillium, Inc.股票出现异动，股价急速跳水6.01%。截至发稿，该股报1.72美元/股，成交量5.1943万股，换手率0.09%，振幅8.16%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为1.89%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。该公司的其他临床阶段和临床前阶段候选药物包括EQ101和EQ302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226230200a4cc0a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226230200a4cc0a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613217980","title":"Equillium, Inc.盘中异动 早盘快速跳水5.49%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613217980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613217980?lang=zh_cn&edition=full","pubTime":"2026-02-20 22:47","pubTimestamp":1771598838,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日22时47分，Equillium, Inc.股票出现异动，股价大幅下挫5.49%。截至发稿，该股报1.72美元/股，成交量1.644万股，换手率0.03%，振幅4.40%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220224718954187c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220224718954187c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602341763","title":"Equillium, Inc.盘中异动 大幅下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602341763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602341763?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:45","pubTimestamp":1767883509,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日22时45分，Equillium, Inc.股票出现异动，股价急速下跌5.34%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108224509a4ac8534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108224509a4ac8534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601335184","title":"Equillium, Inc.盘中异动 快速拉升5.27%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601335184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601335184?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:35","pubTimestamp":1767796503,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日22时35分，Equillium, Inc.股票出现异动，股价急速拉升5.27%。截至发稿，该股报1.36美元/股，成交量2.6366万股，换手率0.04%，振幅3.10%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107223504a6ff2b23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107223504a6ff2b23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588018744","title":"七座版奔驰GLC EQ首曝：车身加长 迎合中国市场需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2588018744","media":"IT之家","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588018744?lang=zh_cn&edition=full","pubTime":"2025-12-03 14:11","pubTimestamp":1764742281,"startTime":"0","endTime":"0","summary":"IT之家 12 月 3 日消息，汽车媒体 CarScoops 昨日 发布博文，报道称在慕尼黑车展发布 GLC EQ 五座版后，梅赛德斯-奔驰斯正在测试一款体型更大、采用三排七座的变体车型。外观方面，七座版 GLC EQ 延续了标准版的设计语言，但在 B 柱之后进行了显著调整。该媒体认为，这款三排座纯电跨界车主要是为了迎合中国市场对大空间、多座位车型的偏好而设计。IT之家附上相关图片如下：","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8omctTD8nZW","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["CWEB","CHAU","BK4588","KWEB","FXI","BK4585","ASHS","ASHR","DRAG","CQQQ","YINN","MCHI","BK4139","BK4614","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2518372274","title":"Equillium, Inc.盘中异动 早盘大幅下挫8.13%报0.731美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518372274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518372274?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:56","pubTimestamp":1741614969,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时56分，Equillium, Inc.股票出现异动，股价大幅下跌8.13%。截至发稿，该股报0.731美元/股，成交量4859股，换手率0.01%，振幅3.64%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2936.57%、644.95%、177.16%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Impact Biomedical, Inc.，振幅分别为40.24%、30.52%、28.59%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215610abf305cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215610abf305cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517193777","title":"Equillium, Inc.盘中异动 快速拉升5.57%报0.760美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517193777?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:26","pubTimestamp":1741282006,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时26分，Equillium, Inc.股票出现波动，股价快速上涨5.57%。截至发稿，该股报0.760美元/股，成交量2.5922万股，换手率0.07%，振幅7.92%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012646963c6cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012646963c6cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516663928","title":"Equillium, Inc.盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663928?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:37","pubTimestamp":1741034264,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时37分，Equillium, Inc.股票出现波动，股价大幅下挫5.73%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Celularity Inc C/Wts 16/07/2026 涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为215.52%、187.68%、163.60%，振幅较大的相关个股有Radiopharm Theranostics Limited、Entero Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为119.50%、70.53%、64.88%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040437449637fdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040437449637fdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514680753","title":"OpenAI发布GPT-4.5！史上最贵AI模型，情商逆天引热议，AI巨头混战即将打响","url":"https://stock-news.laohu8.com/highlight/detail?id=2514680753","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514680753?lang=zh_cn&edition=full","pubTime":"2025-02-28 08:49","pubTimestamp":1740703799,"startTime":"0","endTime":"0","summary":"2月28日凌晨，OpenAI正式发布了其最新一代基础模型GPT-4.5，这一发布迅速在科技界引起了轩然大波。这款被OpenAI内部代号为“Orion”的模型，不仅被誉为迄今为止规模最大、知识最丰富的聊天模型，更因其高情商和人性化表现而备受瞩目。价格昂贵，引发争议然而，GPT-4.5的高昂价格也成为了人们热议的话题。值得一提的是，OpenAI还计划在未来向免费用户开放GPT-5的使用权限。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/28084948444186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514354332","title":"实测GPT4.5：更像人了，有惊喜但提升微妙","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354332","media":"AI寒武纪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354332?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:11","pubTimestamp":1740697866,"startTime":"0","endTime":"0","summary":"北京时间凌晨4点钟OpenAI举行一个14分钟左右的直播发布，GPT4.5 终于发布了！知识更渊博，能力更全面除了情商升级， GPT-4.5 的知识储备和能力也得到了显著提升。这次的 GPT-4.5 更是吊足了大家的胃口，毕竟距离 GPT-4 发布已经过去大约两年了！GPT-4: 感觉确实更好，但 Karpathy 也坦言，提升是 微妙的 。GPT-4.5：微妙的提升，依旧令人兴奋带着对 GPT-4 这种“微妙提升”的预期，Karpathy 对 GPT-4.5 进行了测试。这次 GPT-4.5 的预训练算力比 GPT-4 又提升了 10 倍！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8hKW1DoEdqM","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4568","EQ","BK4505","BK4531","BK4139","BK4108","BK4526","BK4552"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514531453","title":"ChatGPT4.5凌晨发布：不是推理模型，胜似推理模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2514531453","media":"凤凰网科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514531453?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:31","pubTimestamp":1740691902,"startTime":"0","endTime":"0","summary":"凤凰网科技讯 2月28日，OpenAI发布了旗下最新一代大语言模型GhatGPT4.5。相较于GPT-4，GPT-4.5在多个方面进行了优化。GPT-4.5在用户交互中的表现更加自然，知识覆盖面更广，能更好地理解并响应用户的意图。回答问题更加严谨GPT-4.5的核心进展在于其无监督学习的提升。通过增加计算能力和数据规模，GPT-4.5在处理复杂任务时显示出更高的准确性，尤其是在减少“幻觉”现象方面表现突出。OpenAI表示，GPT-4.5仍处于研究预览阶段，未来将继续优化，以便更好地服务于各行各业的需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8hKW1DoEdbw","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["EQ","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514132339","title":"Equillium, Inc.盘中异动 股价大涨5.87%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514132339?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:59","pubTimestamp":1740682746,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时59分，Equillium, Inc.股票出现波动，股价大幅上涨5.87%。截至发稿，该股报0.810美元/股，成交量2.9874万股，换手率0.08%，振幅6.54%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1880.38%、320.93%、136.91%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.84%、52.94%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514866643","title":"Equillium, Inc.盘中异动 快速跳水5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866643?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:07","pubTimestamp":1740593254,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时07分，Equillium, Inc.股票出现异动，股价急速下跌5.78%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6400.71%、261.96%、239.71%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pds Biotechnology Corporation，振幅分别为194.07%、49.18%、44.44%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020734a255286e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020734a255286e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514539578","title":"梅赛德斯-奔驰将逐步淘汰电动汽车“EQ+X”命名，以“配备 EQ 技术”取代","url":"https://stock-news.laohu8.com/highlight/detail?id=2514539578","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514539578?lang=zh_cn&edition=full","pubTime":"2025-02-26 10:26","pubTimestamp":1740536777,"startTime":"0","endTime":"0","summary":"根据外媒 Automotive News Europe 报道，梅赛德斯-奔驰正逐步淘汰电动汽车上的 EQ 前缀，未来将改用“配备 EQ 技术”后缀 ，而插电式混合动力车型则会添加“配备 EQ 混合动力技术”标签。梅赛德斯-奔驰的一位发言人表示，“我们正在强化传统的命名逻辑，未来新车型将不再使用‘EQ’。”梅赛德斯-奔驰并非唯一调整命名的欧洲豪华品牌。","market":"hk","thumbnail":"https://k.sinaimg.cn/n/spider20250226/697/w959h538/20250226/cec8-2c1c922f81bf06deb8a90e9f413caf31.jpg/w120h90l50t15f2.jpg","type":0,"news_type":0,"thumbnails":["https://k.sinaimg.cn/n/spider20250226/697/w959h538/20250226/cec8-2c1c922f81bf06deb8a90e9f413caf31.jpg/w120h90l50t15f2.jpg"],"rights":{"source":"sina_tech","url":"https://tech.sina.cn/mobile/xp/2025-02-26/detail-inemukxn8238835.d.html?vt=4","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}.weibo_user{#sourceStyle#; margin-bottom: 0; display: inline-block;}.weibo_time{#sourceStyle#};","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .j_float_wbro, .j_article_wbreco","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.sina.cn/mobile/xp/2025-02-26/detail-inemukxn8238835.d.html?vt=4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_tech","symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514001149","title":"Equillium, Inc.盘中异动 快速跳水6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514001149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514001149?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:21","pubTimestamp":1740500464,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时21分，Equillium, Inc.股票出现波动，股价快速下跌6.19%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1323.39%、1114.16%、898.01%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002105a2539ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002105a2539ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.equilliumbio.com","stockEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":-0.03},{"period":"3month","weight":0.2989},{"period":"6month","weight":1.3542},{"period":"1year","weight":4.7071},{"period":"ytd","weight":0.4581}],"compareEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.0815},{"period":"6month","weight":0.1314},{"period":"1year","weight":0.2788},{"period":"ytd","weight":0.0934}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Equillium, Inc.于2017年3月16日在特拉华州注册成立，该公司前身为Attenuate Biopharmaceuticals，Inc.。该公司是一家生物技术创新企业，致力于开发治疗严重自身免疫和炎症性疾病的新型疗法。其主要候选药物EQ504是一种处于临床前阶段的AhR调节剂，最初靶向溃疡性结肠炎，此外还包括一个处于临床前阶段、用于胃肠道适应症的口服双特异性抑制剂项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.054449},{"month":2,"riseRate":0.625,"avgChangeRate":0.322617},{"month":3,"riseRate":0.375,"avgChangeRate":-0.15431},{"month":4,"riseRate":0.375,"avgChangeRate":-0.117774},{"month":5,"riseRate":0.75,"avgChangeRate":0.045485},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.151956},{"month":7,"riseRate":0.571429,"avgChangeRate":0.329165},{"month":8,"riseRate":0.714286,"avgChangeRate":0.556288},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.085401},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.070521},{"month":11,"riseRate":0.25,"avgChangeRate":-0.089283},{"month":12,"riseRate":0.5,"avgChangeRate":-0.014533}],"exchange":"NASDAQ","name":"Equillium Inc.","nameEN":"Equillium Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Equillium Inc.,EQ,Equillium Inc.股票,Equillium Inc.股票老虎,Equillium Inc.股票老虎国际,Equillium Inc.行情,Equillium Inc.股票行情,Equillium Inc.股价,Equillium Inc.股市,Equillium Inc.股票价格,Equillium Inc.股票交易,Equillium Inc.股票购买,Equillium Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}